Imperial College London

ProfessorSanjayPrasad

Faculty of MedicineNational Heart & Lung Institute

Professor of Cardiomyopathy
 
 
 
//

Contact

 

+44 (0)20 7352 8121s.prasad

 
 
//

Location

 

CMR UnitRoyal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Celutkiene:2020:10.1002/ejhf.1957,
author = {Celutkiene, J and Pudil, R and Lopez-Fernandez, T and Grapsa, J and Nihoyannopoulos, P and Bergler-Klein, J and Cohen-Solal, A and Farmakis, D and Tocchetti, CG and von, Haehling S and Barberis, V and Flachskampf, FA and Ceponiene, I and Haegler-Laube, E and Suter, T and Lapinskas, T and Prasad, S and de, Boer RA and Wechalekar, K and Anker, MS and Iakobishvili, Z and Bucciarelli-Ducci, C and Schulz-Menger, J and Cosyns, B and Gaemperli, O and Belenkov, Y and Hulot, J-S and Galderisi, M and Lancellotti, P and Bax, J and Marwick, TH and Chioncel, O and Jaarsma, T and Mullens, W and Piepoli, M and Thum, T and Heymans, S and Mueller, C and Moura, B and Ruschitzka, F and Zamorano, JL and Rosano, G and Coats, AJS and Asteggiano, R and Seferovic, P and Edvardsen, T and Lyon, AR},
doi = {10.1002/ejhf.1957},
journal = {EUROPEAN JOURNAL OF HEART FAILURE},
pages = {1504--1524},
title = {Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)},
url = {http://dx.doi.org/10.1002/ejhf.1957},
volume = {22},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Celutkiene,J
AU - Pudil,R
AU - Lopez-Fernandez,T
AU - Grapsa,J
AU - Nihoyannopoulos,P
AU - Bergler-Klein,J
AU - Cohen-Solal,A
AU - Farmakis,D
AU - Tocchetti,CG
AU - von,Haehling S
AU - Barberis,V
AU - Flachskampf,FA
AU - Ceponiene,I
AU - Haegler-Laube,E
AU - Suter,T
AU - Lapinskas,T
AU - Prasad,S
AU - de,Boer RA
AU - Wechalekar,K
AU - Anker,MS
AU - Iakobishvili,Z
AU - Bucciarelli-Ducci,C
AU - Schulz-Menger,J
AU - Cosyns,B
AU - Gaemperli,O
AU - Belenkov,Y
AU - Hulot,J-S
AU - Galderisi,M
AU - Lancellotti,P
AU - Bax,J
AU - Marwick,TH
AU - Chioncel,O
AU - Jaarsma,T
AU - Mullens,W
AU - Piepoli,M
AU - Thum,T
AU - Heymans,S
AU - Mueller,C
AU - Moura,B
AU - Ruschitzka,F
AU - Zamorano,JL
AU - Rosano,G
AU - Coats,AJS
AU - Asteggiano,R
AU - Seferovic,P
AU - Edvardsen,T
AU - Lyon,AR
DO - 10.1002/ejhf.1957
EP - 1524
PY - 2020///
SN - 1388-9842
SP - 1504
TI - Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
T2 - EUROPEAN JOURNAL OF HEART FAILURE
UR - http://dx.doi.org/10.1002/ejhf.1957
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000599099200002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 22
ER -